Want to join the conversation?
$RSG reaffirmed its 2016 EPS guidance of $1.70-1.74 and adjusted EPS forecast of $2.13-2.17. The company also reaffirmed its 2016 adjusted free cash flow guidance of $820-840MM and cash provided by operating activities estimate of $1.778-1.798Bil.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.